Amgen acquires Dark Blue Therapeutics to fight Acute Myeloid Leukemia. See how this $840M deal aims to deliver first-in-class ...

An Australian research collaboration has led to a major leap forward in the treatment of acute lymphoblastic leukemia (ALL). Recently published clinical trial results have shown evidence that ...

SEER based nomograms predicted overall and cancer specific survival in acute erythroid leukemia, with age and chemotherapy ...

Increased infection risk seen with more liberalized diet for patients undergoing HSCT or induction chemotherapy for acute leukemia.

Researchers identify beta catenin protein degradation as a therapeutic vulnerability in B cell acute lymphoblastic leukaemia, supporting the repurposing of glycogen synthase kinase 3 beta inhibitors.

QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its ...

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat ® KMT2A + MRD Assay and Software to its industry-leading ...

The death was confirmed by her husband, Brandon Paul, in a 10-minute Facebook video shared on January 22, 2026.

The diagnosis of acute leukaemia in children, most notably acute lymphoblastic leukaemia (ALL), remains a critical challenge in paediatric medicine. A significant proportion of patients present with ...

Revuforj is approved for relapsed or refractory acute leukemia with KMT2A translocation in patients aged 1 year and older. The AUGMENT-101 trial showed a 21.2% complete remission rate with a median ...

Patients with acute leukemia prioritize tiredness as the most important health dimension over cognition, differing from the general public's preferences. Informal caregivers report significant ...